Catalyst Pharmaceuticals (CPRX) Assets Average (2011 - 2026)

Catalyst Pharmaceuticals (CPRX) has 16 years of Assets Average data on file, last reported at $1.1 billion in Q1 2026.

• For the quarter ending Q1 2026, Assets Average rose 27.91% year-over-year to $1.1 billion; the trailing twelve-month figure through Mar 2026 stood at $1.1 billion (up 27.91% YoY), and the FY2025 full-year result was $977.7 million, up 47.96% from the prior year.
• Assets Average for Q1 2026 stood at $1.1 billion, up from $1.1 billion in the prior quarter.
• Across five years, Assets Average topped out at $1.1 billion in Q1 2026 and bottomed at $242.4 million in Q1 2022.
• The 5-year median for Assets Average is $558.4 million (2024), against an average of $627.2 million.
• The widest annual swing landed in 2022, when Assets Average climbed 24.43%; it then surged 83.79% in 2024.
• A 5-year view of Assets Average shows it stood at $354.4 million in 2022, then advanced by 24.63% to $441.7 million in 2023, then jumped by 83.79% to $811.7 million in 2024, then soared by 32.78% to $1.1 billion in 2025, then climbed by 4.45% to $1.1 billion in 2026.
• The last three Assets Average figures came in at $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.0 billion (Q3 2025), per Business Quant data.

Peer Comparison